Medicenna Therapeutics

Located in Toronto, Canada, Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Superkines for the treatment of a broad range of cancers.